Latest Licensing News

Whitehaven Coal reported a robust FY25 with $1.4 billion underlying EBITDA and strong production growth from Queensland acquisitions, maintaining a solid balance sheet and setting ambitious cost-saving targets for FY26.

Li-S Energy Limited reported a $6.41 million net loss for FY25 while making significant strides in commercialising its lithium-sulfur battery technology, including commissioning new production facilities and securing key strategic partnerships.

Octava Minerals reports impressive initial bioleaching recoveries of critical rare earth elements and lithium from its Byro Project, highlighting a promising, low-cost extraction pathway.

Iris Cairns Property Pty Ltd has increased its cash takeover offer for Reef Casino Trust units to A$3.72 per unit, with the Reef Corporate Services Limited board unanimously recommending acceptance. The offer values the trust at approximately A$185.3 million and awaits regulatory approvals.

Opthea Limited has terminated its sozinibercept wet AMD program following Phase 3 trial failures and settled a major funding agreement, setting the stage for a strategic reset.

Etherstack plc has delivered a record half year performance in H1 2025, driven by a landmark multi-year contract with AT&T and surging recurring revenues. The wireless communications specialist is poised for sustained growth across its core markets.

Orpheus Uranium Limited has completed the acquisition of key exploration licenses in South Australia's Pirie Basin, expanding its uranium exploration footprint in a promising sedimentary uranium province.

dorsaVi Ltd has unveiled Artemis Labs, a new subsidiary focused on developing advanced AI, sensor, and robotics technologies powered by cutting-edge RRAM. This initiative aims to transform human movement data into intelligent robotic and healthcare applications.

Felix Group Holdings reports a solid 22% increase in FY25 sales revenue and a notable 32% improvement in adjusted EBITDA loss, driven by strong enterprise platform sales and new customer wins.

Ausmon Resources has addressed a recent spike in its share price and trading volume, attributing the market interest to prior drilling assay results for rare earth elements in South Australia.

AdAlta Limited outlines its innovative 'East to West' cellular immunotherapy approach, in-licensing Asian CAR-T assets and progressing clinical trials in Australia to unlock value. The company also seeks partners for its anti-fibrotic and anti-malarial protein therapeutics.

Opthea has successfully settled its Development Funding Agreement, avoiding a potential $680 million liability and securing $20 million in cash. Leadership changes include the CEO and CFO stepping down, with the Chairman assuming CEO duties.